Home » Newsletters » BioWorld Science

BioWorld Science

Dec. 20, 2012

View Archived Issues

Ciclopiroxolamine evaluated in patients with hematological malignancies

Mouse model mimics characteristics of Tourette syndrome observed in patients

Soligenix acquires innate defense regulator

Neurocrine begins second phase IIb study of NBI-98854

Primary endpoint not met in phase III trial of L-BLP25 in NSCLC

iPSC-derived neurons as a model for AD treatment screening / News in Context

Japanese and U.S. group patents novel TRPV1 channel antagonists

Principia Biopharma discloses new protein kinase inhibitors

Gentium provides update on MAA for defibrotide

Arrowhead and Shire enter agreement to develop peptide-targeted therapeutics

MAA filed in Japan for additional pediatric indication of topiramate

Concert Pharmaceuticals synthesizes new deuterated CFTR activators

NewGen Therapeutics patents new agents for cancer

Novel antitumor metal complexes designed by Unitech

University of Toyama prepares new beta-carboline derivatives for cancer

IPI-145 well tolerated and active in patients with hematological malignancies

Researchers present clinical trial results on NOX-H94 for the treatment of ACD

Intercell obtains positive CHMP opinion for pediatric use of its JE vaccine

Amgen licenses rights to TAP technology for third cancer target

Allon Therapeutics' phase II/III trial of davunetide fails to show efficacy

UMN Pharma signs license agreement with Ildong Pharmaceutical for influenza vaccines

GlycoVaxyn and GSK enter collaboration to develop new bacterial vaccines

Idera Pharmaceuticals reports results from phase IIa IMO-3100 trial

Intercept Pharmaceuticals completes enrollment in phase III POISE Trial

MethylGene's phase II trial of MGCD-290 completes enrollment

Prana Biotechnology completes recruitment in Reach2HD study

BAY-80-6946 activity in non-Hodgkin's lymphoma leads to phase II study

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...